Citation Impact
Citing Papers
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
Platelet gene expression and function in patients with COVID-19
2020 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation
2010
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
Allogeneic Hematopoietic Cell Transplantation in Human Immunodeficiency Virus–Positive Patients with Hematologic Disorders: A Report from the Center for International Blood and Marrow Transplant Research
2009
No health without mental health
2007 Standout
Autopsy Findings in a Human Immunodeficiency Virus–Infected Population Over 2 Decades
2002
Fungal Phenalenones Inhibit HIV-1 Integrase
2005 StandoutNobel
Clinical and Biological Evolution of HIV-1 Seroconverters in Abidjan, Côte d'Ivoire, 1997–2000
2002 StandoutNobel
Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study
2010
Treatment of antiretroviral-drug-resistant HIV-1 infection
2003
Modelling the Impact of Antiretroviral Use in Resource-Poor Settings
2006
Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection
2006 StandoutNobel
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients
2003
CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years<subtitle>The Swiss HIV Cohort Study</subtitle>
2003
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS
2015
National review of first treatment change after starting highly active antiretroviral therapy in antiretroviral‐naïve patients
2007
Updated US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis
2013
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
The Neglected Tropical Diseases of Latin America and the Caribbean: A Review of Disease Burden and Distribution and a Roadmap for Control and Elimination
2008 Standout
The Changing Pattern of AIDS-defining Illnesses with the Introduction of Highly Active Antiretroviral Therapy (HAART)in a London Clinic
2001
HIV-associated neurologic disease incidence changes:
2001
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies
2008
Lipodystrophy Syndromes
2008
A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells
2016 StandoutNobel
Global cancer statistics
2011 Standout
Intestinal parasitic infections in HIV/AIDS patients: Experience at a teaching hospital in central Brazil
2004
Thrice-Weekly Sulfadiazine-Pyrimethamine for Maintenance Therapy of Toxoplasmic Encephalitis in HIV-Infected Patients
2000
Design of dimerization inhibitors of HIV-1 aspartic proteinase: A computer-based combinatorial approach
2000 StandoutNobel
The role of sexually transmitted diseases in HIV transmission
2004 Standout
Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals
2018
The growing impact of click chemistry on drug discovery
2003 StandoutNobel
Resistance to Protease Inhibitors
2001
Dynamics and functions of lipid droplets
2018 Standout
Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study
2002
The end of AIDS: HIV infection as a chronic disease
2013 Standout
ROCR: visualizing classifier performance in R
2005 Standout
Structured Treatment Interruptions for the Management of HIV Infection
2001
Platelet function and HIV: a case–control study
2010
Declining incidence of AIDS-defining opportunistic illnesses
2012
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
2006 Standout
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes
2004
Gene therapy for HIV infection: what does it need to make it work?
2006 StandoutNobel
Changing incidence of AIDS-related Kaposi sarcoma and non-Hodgkin lymphoma in Ontario, Canada
2008
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Tipranavir: a novel protease inhibitor for HIV therapy
2009
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
2009 Standout
Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy
2000
HIV-Related Neuropathology, 1985 to 1999: Rising Prevalence of HIV Encephalopathy in the Era of Highly Active Antiretroviral Therapy
2002
AIDS across Europe, 1994–98: the EuroSIDA study
2000
Antiretroviral Treatment for Adult HIV Infection in 2002
2002
Periodontal diseases
2005 Standout
Neuroglial activation and neuroinflammation in the brain of patients with autism
2004 Standout
Approach to the Treatment-experienced patient
2005
Immunological recovery and antiretroviral therapy in HIV-1 infection
2006
The CD4 lymphocyte count and risk of clinical progression
2006
Dendritic Cell Numbers in the Blood of HIV-1 Infected Patients Before and After Changes in Antiretroviral Therapy
2004 StandoutNobel
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Natural History of Human Immunodeficiency Virus Disease in Southern India
2003
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
2002
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
2003 Standout
Impact of gene-modified T cells on HIV infection dynamics
2005 StandoutNobel
Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study
2009
Not So Different After All: A Comparison of Methods for Detecting Amino Acid Sites Under Selection
2005 Standout
Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design
2005
Platelets in Immune Response to Virus and Immunopathology of Viral Infections
2018
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
1999
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
2007 Standout
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
2002
Antiretroviral Therapy in Adults
2000
Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy
2004
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Reservoirs for HIV-1: Mechanisms for Viral Persistence in the Presence of Antiviral Immune Responses and Antiretroviral Therapy
2000
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Autopsy findings in a human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors, and time.
2002
Variants Other than Aspartic Acid at Codon 69 of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Gene Affect Susceptibility to Nucleoside Analogs
2001
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration
2014 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992–2003
2008
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
The Challenge of Viral Reservoirs in HIV-1 Infection
2002
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis
2006
An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication
2004 StandoutNobel
Naive T-Cell Depletion Related to Infection by X4 Human Immunodeficiency Virus Type 1 in Poor Immunological Responders to Highly Active Antiretroviral Therapy
2006 StandoutNobel
The Influence of Human Immunodeficiency Virus-1 on Hematopoiesis
1998
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
Diversity and complexity of HIV-1 drug resistance: A bioinformatics approach to predicting phenotype from genotype
2002
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
HIV Infection and Dementia
2000 Science
Point-of-Care Diagnostics for Global Health
2008 Standout
High Levels of Viral Replication Contrast with Only Transient Changes in CD4+and CD8+Cell Numbers during the Early Phase of Experimental Infection with Simian Immunodeficiency Virus SIVmnd-1 inMandrillus sphinx
2002 StandoutNobel
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
2006
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies
2003
Nonproliferating Bystander CD4+ T Cells Lacking Activation Markers Support HIV Replication During Immune Activation
2001 StandoutNobel
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies
2007
Resistance to Protease Inhibitors
2001
Host Determinants in HIV Infection and Disease: Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics*
2001
Works of Peter Gute being referenced
γδ-T Cell-Receptor-Positive Lymphocytes Inhibit Human Hematopoietic Progenitor Cell Growth in HIV Type 1-Infected Patients
1996
Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers
2012
First case of successful allogeneic stem cell transplantation in an HIV-patient who acquired severe Aplastic Anemia
2007
Platelet–leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors
2008
Use of Viral Load Measured After 4 Weeks of Highly Active Antiretroviral Therapy to Predict Virologic Outcome at 24 Weeks for HIV-1???Positive Individuals
2004
The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy
2006
Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure
2000
Significant effects of tipranavir on platelet aggregation and thromboxane B2 formation in vitro and in vivo
2007
Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy
1997
Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy
1999
HIV Drug Susceptibility and Treatment Response to Mega-Haart Regimen in Patients from the Frankfurt HIV Cohort
2000
End‐stage renal disease and dialysis in HIV ‐positive patients: observations from a long‐term cohort study with a follow‐up of 22 years
2012
Is transmission of HIV-1 in non-viraemic serodiscordant couples possible?
2008